Earlier today it was announced that the FDA has approved a new production facility for the manufacture of flu vaccines. The facility, based in the U.S. is owned by sanofi pasteur, (a division of our client sanofi-aventis) which manufactures Fluzone Influenza Virus Vaccine. This new facility will greatly increase sanofi pasteur’s production capability.
Congratulations to them. (Send some Fluzone our way!)
My former employer, Bristol-Myers Squibb Co., has announced it is selling its ConvaTec unit for $4.1 billion to two private equity firms: Nordic Capital and Avista Capital Partners. ConvaTec had been Bristol-Myers’ ostomy and surgical equipment.
Apparently, cash will be used to help finance Bristol-Myers’s strategy to shift its focus to biopharmaceuticals.